Show simple item record

dc.contributor.authorMarino, Ryan T.
dc.contributor.authorSpyres, Meghan
dc.contributor.authorWiegand, Timothy J.
dc.contributor.authorBabu, Kavita M.
dc.contributor.authorStolbach, Andrew
dc.date2022-08-11T08:08:28.000
dc.date.accessioned2022-08-23T15:56:19Z
dc.date.available2022-08-23T15:56:19Z
dc.date.issued2022-01-01
dc.date.submitted2022-01-13
dc.identifier.citation<p>Marino RT, Spyres M, Wiegand TJ, Babu KM, Stolbach A. ACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder. J Med Toxicol. 2022 Jan;18(1):71-73. doi: 10.1007/s13181-021-00861-4. Epub 2021 Oct 25. PMID: 34697778. <a href="https://doi.org/10.1007/s13181-021-00861-4">Link to article on publisher's site</a></p>
dc.identifier.issn1556-9039 (Linking)
dc.identifier.doi10.1007/s13181-021-00861-4
dc.identifier.pmid34697778
dc.identifier.urihttp://hdl.handle.net/20.500.14038/29945
dc.description.abstractThe prevalence of opioid use disorder (OUD) in healthcare professionals (HCP) is similar to that of the general population. Identification and treatment of OUD in HCPs is a public health and patient safety issue because HCP behavior impacts patient care. A person with OUD and active substance use may be impaired, that is, unable to practice with reasonable skill and safety due to illness. However, when OUD is treated effectively, impairment may be resolved even though the diagnosis of OUD remains.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=34697778&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1007/s13181-021-00861-4
dc.subjectBuprenorphine
dc.subjectHealth care professionals
dc.subjectImpairment
dc.subjectOpioid use disorder
dc.subjectPhysicians
dc.subjectHealth and Medical Administration
dc.subjectMedical Toxicology
dc.subjectSubstance Abuse and Addiction
dc.titleACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder
dc.typeJournal Article
dc.source.journaltitleJournal of medical toxicology : official journal of the American College of Medical Toxicology
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/faculty_pubs/2149
dc.identifier.contextkey27336865
html.description.abstract<p>The prevalence of opioid use disorder (OUD) in healthcare professionals (HCP) is similar to that of the general population. Identification and treatment of OUD in HCPs is a public health and patient safety issue because HCP behavior impacts patient care. A person with OUD and active substance use may be impaired, that is, unable to practice with reasonable skill and safety due to illness. However, when OUD is treated effectively, impairment may be resolved even though the diagnosis of OUD remains.</p>
dc.identifier.submissionpathfaculty_pubs/2149
dc.contributor.departmentDivision of Medical Toxicology, Department of Emergency Medicine


This item appears in the following Collection(s)

Show simple item record